Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
combination vaccines
Biotech
Moderna's next-gen COVID vax surpasses approved version in ph. 3
Moderna’s next-gen COVID vaccine notched a higher immune response than its licensed counterpart, passing a phase 3 test.
Max Bayer
Mar 26, 2024 10:55am
Moderna's one-two COVID-flu punch matches existing vaccines
Oct 4, 2023 9:55am
After initial stumbles, Moderna gets clean win for mRNA flu shot
Sep 13, 2023 6:30am
Vaccine combo hits back at treatment-resistant cancer
Jun 23, 2022 11:01am
AstraZeneca starts phase 1 of COVID-19 antibodies
Aug 25, 2020 7:35am
